Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines

Oncogene

Volumn 24, Issue 10, 2005, Pages 1767-1773

  Iwakiri, Dai ^a   Sheen, Tzung Shiahn ^b   Chen, Jen Yan ^b   Huang, Dolly Poon ^c   Takada, Kenzo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

EBER; EBV; IGF 1; Nasopharyngeal carcinoma

Indexed keywords

SOMATOMEDIN C; SOMATOMEDIN C ANTIBODY; UNCLASSIFIED DRUG; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 1; MATRIX PROTEIN; VIRUS RNA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; VIRUS INFECTION; GENETICS; NASOPHARYNX TUMOR; PATHOLOGY; PHYSIOLOGY; TRANSACTIVATION; TUMOR CELL LINE;

CELL LINE, TUMOR; HERPESVIRUS 4, HUMAN; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NASOPHARYNGEAL NEOPLASMS; RNA, VIRAL; TRANS-ACTIVATION (GENETICS); VIRAL MATRIX PROTEINS;

EID: 14944353441     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208357     Document Type: Article

References (15)

1. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM and Lee JC. (1999). Int. J. Cancer, 83, 121-126.
2. Fürstenberger G and Senn H-J. (2002). Lancet Oncol., 3, 298-302.
3. Imai S, Nishikawa J and Takada K. (1998). J. Virol., 72, 4371-4378.
4. Iwakiri D, Eizuru Y, Tokunaga M and Takada K. (2003). Cancer Res., 63, 7062-7067.
5. Kieff E and Rickinson AB. (2002). Fields Virology 4th edn. Fields BN, Knipe DM and Howley PM (eds). Lippincott-Raven Publishers: Philadelphia, pp. 2511-2573.
6. Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T, Yasukawa M, Hino K, Suzuki T, Todo M and Takada K. (2000). EMBO J., 19, 6742-6750.
7. Komano J, Maruo S, Kurozumi K and Takada K. (1999). J. Virol., 73, 9827-9831.
8. Maruo S, Yang L and Takada K. (2001). J. Gen. Virol., 82, 2373-2383.
9. Nanbo A, Inoue K, Adachi-Takasawa K and Takada K. (2002). EMBO J., 5, 954-965.
10. Rickinson AB and Kieff E. (2002). Fields Virology 4th edn. Fields BN, Knipe DM and Howley PM (eds). Lippincott-Raven Publishers: Philadelphia, pp. 2575-2627.
11. Sharp TV, Schwemmle M, Jeffrey I, Laing K, Mello H, Proud CG, Hilse K and Clemens MJ. (1993). Nucleic Acids Res., 21, 4483-4490.
12. Yamamoto N, Takizawa T, Iwanaga Y, Shimizu N and Yamamoto N. (2000). FEBS Lett., 484, 153-158.
13. Yao K, Zhang H-Y, Zhu H-C, Wang F-X, Li G-Y, Wen D-S, Li Y-P, Tsa C-HA and Glaser R. (1990). Cancer, 45, 83-89.
14. Yu H and Rohan T. (2000). J. Natl. Cancer Inst., 92, 1472-1489.
15. Zeng S, Wu Y, Zeng Y, Zech L and Klein G. (1982). Hereditas, 97, 23-28.